Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,332,195 papers from all fields of science
Search
Sign In
Create Free Account
Ovarian Carcinoma
Known as:
ovarian ca
, cancer ovary
, ovarian cancer
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Basal Cell Nevus Syndrome
Hamartoma Syndrome, Multiple
Malignant Neoplasms
ovarian carcinosarcoma
Narrower (3)
Epithelial ovarian cancer
Malignant Brenner Tumor
ovarian adenocarcinoma
Broader (3)
Malignant neoplasm of ovary
Neoplasm, uncertain whether benign or malignant
ovarian neoplasm
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Allelic expression of p73 in human ovarian cancers.
A. Codegoni
,
F. Bertoni
,
C. Patregnani
,
E. Marinetti
,
M. D’Incalci
,
M. Broggini
Annals of Oncology
1999
Corpus ID: 22023575
BACKGROUND The p73 gene is structurally related to the tumor suppressor gene p53. The role of p73 in tumor development is still…
Expand
Highly Cited
1985
Highly Cited
1985
Abdominopelvic Computed Tomography: Evaluation in Patients Undergoing Second‐Look Laparotomy for Ovarian Carcinoma
D. Brenner
,
M. Shaff
,
H. Jones
,
W. Grosh
,
F. Greco
,
L. Burnett
Obstetrics and Gynecology
1985
Corpus ID: 8936503
Preoperative abdominopelvic computed tomography results and operative findings were compared in 52 patients undergoing second…
Expand
1985
1985
Second-look laparotomy for ovarian carcinoma.
L. Copeland
Clinical obstetrics and gynecology
1985
Corpus ID: 10548604
At present, the second-look laparotomy is the most reliable method of evaluating the disease status of a patient treated with…
Expand
1985
1985
High-dose cisplatin therapy for cancer of the ovary: neurotoxicity.
C. Bagley
,
R. Rudolph
,
S. Rivkin
,
J. L. Yon
Annals of Internal Medicine
1985
Corpus ID: 34794607
Excerpt To the editor: We wish to call to your readers' attention an unexpectedly severe and disabling neurotoxicity due to very…
Expand
1983
1983
Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma.
P. Gauduchon
,
C. Tillier
,
C. Guyonnet
,
J. Héron
,
E. Bar-Guilloux
,
J. L. Le Talaer
Cancer Research
1983
Corpus ID: 14352948
Serum glycoprotein galactosyltransferase levels were determined in 28 healthy women and 113 patients with ovarian carcinoma with…
Expand
1982
1982
Cellular heterogeneity in human ovarian carcinoma studied by density gradient fractionation.
Mackillop Wj
,
Buick Rn
1982
Corpus ID: 89499532
: We have utilized equilibrium density gradient sedimentation to document the cellular heterogeneity existing in tumor cell…
Expand
1981
1981
Probability models in the analysis of radiation-related complications: utility and limitations.
R. Potish
,
J. Boen
,
T. Jones
,
S. Levitt
Radiology
1981
Corpus ID: 27722707
In order to predict radiation-related enteric damage, 92 women were studied who had received identical radiation doses for cancer…
Expand
1977
1977
Chemotherapy of murine ovarian carcinoma by methotrexate-antibody conjugates.
S. Burstein
,
R. Knapp
Journal of Medicinal Chemistry
1977
Corpus ID: 39200887
Antibodies with specificity for an experimental ovarian carcinoma were coupled to methotrexate by two procedures. Water-soluble…
Expand
1977
1977
Postoperative Use of Radioactive Phosphorus in Stage I Ovarian Carcinoma
S. Alderman
,
T. Dillon
,
M. S. Krummerman
,
B. Phillips
,
A. Chung
Obstetrics and Gynecology
1977
Corpus ID: 8120090
The addition of intraperitoneal colloidal radioactive chromic phosphorus following total abdominal hysterectomy, bilateral…
Expand
Review
1970
Review
1970
Evaluation of rare adverse effects of systemic contraceptives.
R. Doll
,
M. Vessey
British Medical Bulletin
1970
Corpus ID: 30701667
Accurate evaluation of side effects of oral contraceptives is complicated by the unknown degree of incompleteness of the medical…
Expand